Roche Holding saw its EPS decline at a compound rate of 6.7% per year, over the last three years. This reduction in EPS is ...

An Alzheimer’s drug from Roche cleared a protein that’s a hallmark of the disease from patients’ brains, suggesting the drug ...

Roche Holding has one of the most promising treatments for Alzheimer’s in clinical trials. The drug is several years away ...

An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...

Roche Bros. said in a social media post the sale means “no changes in day-to-day operations,” and the company will have the ...

Seventy-two years after the Roche family opened a meat market that grew into a Massachusetts supermarket chain, the family is ...

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...

Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...

The trial data showed that the company’s Elecsys amyloid plasma panel could rule out Alzheimer’s with a negative predictive ...

In a report released on November 1, David Evans from Kepler Capital maintained a Buy rating on Roche Holding AG (RHHVF – Research Report), with a price target of CHF315.00. The company’s shares closed ...

Alongside opening the new offices, Roche Diagnostics' capabilities in China have been further recognised as it has been ...

The family that started the Roche Bros. supermarket chain over 70 years ago is selling a controlling interest in the local company to its longtime supplier in Connecticut. The Mansfield-based grocer ...